Before The Bell
FONT-SIZE Plus   Neg

Amarin Corp. (AMRN) Fell To Over A 6-Month Low

Trade AMRN now with 

Amarin Corp. (AMRN: Quote) announced a $100 million non-equity financing after the bell Thursday with an investment fund managed by Pharmakon Advisors. Amarin is continuing its preparations to commercialize Vascepa capsules with the hiring of a sales force in the United States.

Amarin gapped open sharply lower Friday, but traded in a narrow range throughout the session. The stock closed down by 2.26 at $9.69, with volume at over a 4-month high. Amarin dropped below a 2-month range and set over a 6-month low.

Click here to receive FREE breaking news email alerts for Amarin Corp Plc and others in your portfolio

by RTT Staff Writer

For comments and feedback:

Business News

comments powered by Disqus